Polysil Irrigation Systems Limited

Sector n/a · NSE

₹32.50−₹0.05 (−0.15%)

DalalBaazaar Score

47 / 100

🟡 Moderate

Verdict

NEUTRAL

Risk

High

Driven by negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:07 pm

Mixed / neutral. No major red flags jump out, but nothing here screams "obviously cheap" either. This is a name that needs a peer comparison and a view on near-term earnings triggers before sizing a position.

Understanding the Business

The 60-second version of Polysil Irrigation Systems Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

How does it make money?

Turns over ₹46 Cr a year. Of every ₹100 of sales, about ₹6 reaches shareholders as profit, with ₹14 left at the operating level before interest, tax and depreciation.

EBITDA margin14.2%

Net margin6.2%

What is its competitive advantage?Little sign of one

Returns on capital of 9.4% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

ROCE9.4%

ROE4.9%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +4% while net margin moved +211% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+4%

Margin effect+211%

DalalBaazaar Score

47/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

49/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

35/ 100

Expensive

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

vs. its own history

Not enough price and earnings history

vs. sector peers

Not enough peers with a usable P/E

vs. generic bands

No P/E available

P/E (Trailing)

—

P/B

—

EV/EBITDA

16.7x

PEG

—

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well1

Margins are improving
EBITDA margin is up from 10.1% to 14.2% over 3 years.

🔴 What Needs Attention5

Debt is rising
Total debt is up 128% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Return on capital is falling
ROCE has declined from 17.6% to 9.4% — often a sign of competition or overexpansion.
Receivables growing faster than sales
Receivables are up 86% against revenue growth of 4% — customers are taking longer to pay.
Inventory building faster than sales
Inventory is up 169% against revenue growth of 4% — stock may not be moving.

Red Flags

6 items require attention · 4 high · 2 watch

🔴Debt has risen sharplyFinancial
Total debt is up 128% over 3 years, from ₹15 Cr to ₹35 Cr.
🔴Profit up while operating cash flow fallsFinancial
Reported profit rose but cash generated by operations declined — worth checking whether earnings are being supported by non-cash items or working capital.
🔴Receivables growing faster than salesFinancial
Receivables up 86% against revenue up 4% — sales are being booked faster than they are collected.
🔴Inventory building faster than salesFinancial
Inventory up 169% against revenue up 4% — stock may not be moving.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹49 Cr in the latest year.
🟡Shareholders have been dilutedOwnership
Shares outstanding are up 98% over 3 years — each existing share owns a smaller slice of the company.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Margin expansion has further to run
EBITDA margin has risen from 10.1% to 14.2%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.

🔴 Bear CaseWhat could go wrong?

The debt load needs earnings to hold up
Debt is 5.5x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
Sales are being booked faster than collected
Receivables are up 86% against revenue up 4%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
Growth barely outpaces inflation
Revenue compounding at 1.3% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 12%✓ 14.2%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Debt / EBITDA falls below 3x✗ 5.5x
Already stretched, so this is a reduction target rather than a level to hold. Around 3x is where lenders typically start attaching conditions.
3Free cash flow remains positive✗ -₹49 Cr
Profit that never becomes cash eventually stops being profit.
4Interest cover stays above 3x✗ 2.5x
How much operating profit can fall before interest stops being comfortably covered.
5Revenue growth stays above 4% a year✗ 1.3% CAGR
Latest reported year was 228.2%. The bar is set below the established compounding rate, so ordinary variation does not trip it.

Investment Checklist

4 / 9 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

2 good · 7 neutral · 2 weak

Market Cap

₹73 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

Not available

No data

Source didn't return this field

P/B Ratio

Not available

No data

Source didn't return this field

EPS (TTM)

Not available

No data

Source didn't return this field

ROE

4.9%

Weak

Weak capital efficiency

ROCE

9.4%

Moderate

Moderate return on the capital in the business

Debt/Equity

0.61x

Moderate

Moderate leverage

Revenue Growth (YoY)

228.2%

Healthy

Healthy top-line growth

Profit Growth (YoY)

251.6%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹49 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹32.5

Gross Margin

23.3%

Proxy

Operating margin unavailable — showing gross margin instead

Net Margin

6.2%

Average

Average bottom-line conversion

Current Ratio

1.33

Comfortable

Healthy short-term liquidity

Technical Snapshot

SMA 20 / SMA 50

57.3 / 63.9

Bearish alignment (short < long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

31.5

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹44 Cr	₹44 Cr	₹14 Cr	₹46 Cr	+1.3%
EBITDA	₹4 Cr	₹5 Cr	₹1 Cr	₹6 Cr	+13.4%
EBITDA Margin	10.1%	11.6%	8.5%	14.2%	—
PAT (Net Profit)	₹1 Cr	₹2 Cr	-₹2 Cr	₹3 Cr	+47.9%
EPS	₹0.77	₹2.06	—	—	—
ROE	5.7%	8.1%	-8.0%	4.9%	—
ROCE	17.6%	14.9%	1.7%	9.4%	—
Total Debt	₹15 Cr	₹17 Cr	₹17 Cr	₹35 Cr	+31.6%
Free Cash Flow	₹0 Cr	-₹6 Cr	₹3 Cr	-₹49 Cr	—

🟡 Revenue has been broadly flat over 3 years (1.3% a year).

🟢 EBITDA has grown at 13.4% a year over 3 years.

🟢 EBITDA Margin has risen from 10.1% to 14.2% over 3 years (+4.1 pts).

🟢 PAT (Net Profit) has grown at 47.9% a year over 3 years.

🟡 ROE has held roughly flat at 4.9% over 3 years.

🔴 ROCE has fallen from 17.6% to 9.4% over 3 years (-8.2 pts).

🔴 Total Debt has grown at 31.6% a year over 3 years.

🔴 Free Cash Flow has turned negative, from ₹0 Cr to -₹49 Cr.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹131 Cr

Total Liabilities

₹74 Cr

Total Debt

₹35 Cr

Cash & Equivalents

₹1 Cr

Operating Cash Flow

-₹48 Cr

Capex

-₹1 Cr

Recent News

1 mixed5 general

Polysil Irrigation Systems Lower Circuit Streak: Day 2 Price and Data

Univest, 06 Oct

Polysil Irrigation Systems Ltd Key Financial Ratios – Valuation, Profitability & More

Value Research, 21 Sept

Polysil Irrigation Systems publishes FY26 audited results

scanx.trade, 31 MayResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Polysil Irrigation Systems Ltd. Share Price: A 9.97% Drop

Univest, 05 Aug

Polysil Irrigation Systems Ltd Peer Comparison – Compare with Others

Value Research, 30 Aug

Polysil Irrigation Systems (NSEI:POLYSIL) - Stock Analysis

Simply Wall Street, 16 Feb

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.
Sector/industry classification unavailable — verify manually for peer comparison.
3 metrics couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.

DalalBaazaar Thesis

🔴Business QualityWeak7.5/20

🟡Financial HealthAdequate9.8/20

🟢GrowthStrong13.1/20

🔴ProfitabilityWeak6.2/15

🟡ValuationFair7.5/15

🔴RiskHigh2.5/10

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 4 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓EBITDA margin holds above 12%14.2%
✗Debt / EBITDA falls below 3x5.5x
✗Free cash flow remains positive-₹49 Cr
✗Interest cover stays above 3x2.5x
✗Revenue growth stays above 4% a year1.3% CAGR